Searched for
ABSL PHARMA FUND
Every dip now a good buying opportunity: Mahesh PatilMahesh Patil of ABSL AMC believes the impact of US tariffs on India will be limited, causing a slight decline in certain sectors like IT an...- Why is the market rally broadening? A Balasubramanian explainsA Balasubramanian, MD of ABSL AMC, discusses current investment trends in the Indian equity market. He also notes the inflows into largecap...
- Investing in thematic funds? Key factors you should keep in mindRustagi advises cautious investment in thematic funds, considering government focus areas like defence, infrastructure, and pharma post-ele...
- 4 sectors Mahesh Patil is bullish on for near termDespite concerns over growth slowing down and earnings downgrades, the Indian market is creating a good support for a medium to long-term m...
- Valuations to remain high within the FMCG sector: Mahesh PatilWithin that the government spending on infrastructure in this budget we have seen a significant increase on that especially into a rail in ...
- ABSL Flexi cap mutual fund review: Needs a sharp turnaround; should you stay invested?While the fund’s longer term track record in the hands of its long serving fund manager is healthy, its performance has dipped since 2020, ...
- Year-End Special: IT sector funds lost 18% in 2022. What is in store for 2023?Among the sectoral funds, IT has been the worst affected this year. While infra and banking funds are up about 11% and 21% respectively, ph...
- Quant ESG Fund offers 25% returns in a year amid global uncertaintiesThe Quant ESG Fund is one-year old and is the topper in the category, where a few schemes like Invesco India ESG Fund, ABSL ESG Fund and Ax...
- After initial correction, market to scale new highs next year: Mahesh Patil“As we move into next year, we still expect double digit earnings growth. There will be periods of volatility and some corrections next yea...
- ABSL Frontline Equity mutual fund review: Why you should avoid the scheme for nowThe fund went through a prolonged lean phase between 2017-20 but put up a strong show last year. However, it has slipped again this year, l...
- Will my mutual funds help me create Rs 10 crore in 25 years?If you have any mutual fund queries, message on ET Mutual Funds on Facebook. We will get it answered by our panel of experts.
- Investors flock towards sector funds offering 135-145% returnsSectoral and thematic funds have been on top of the return charts in the last one year. The higher returns have resulted in a lot of tracti...
- Covid won’t dampen medium-term outlook for real estate: Mahesh Patil“Covid will have some dampening effect in the near term but should not alter the long-term outlook in real estate.”
- It’s tough to get rich in one year, but a tilt towards equity helps: Mahesh PatilLook at some of the less risky options on the equity side -- be it the asset allocation fund or the balanced advanced fund. That would do w...
- 6 mutual fund categories that offered 20% plus returns in 2020Despite the long shadow cast by the Covid-19 pandemic, several mutual fund categories rewarded patient investors handsomely in 2020.
- Do thematic mutual funds really add value to your investment portfolio?The newer thematic funds may be interesting and promising concepts, but have not yet established credentials as dependable, long-term strat...
- Fund in focus: Should you stop/sell your investments in Aditya Birla Sun Life Pure Value Fund?ABSL Pure Value Fund has been underperforming its benchmark and category average for around three years and financial planners have been as...
- Can I create Rs 2 crore for my retirement with these mutual funds?If you have any mutual fund queries, message ET Mutual Funds on Facebook. We will get it answered by our panel of experts.
- Investors review MF portfolios early due to high return difference between schemesGone are the days when you could buy a mutual fund and leave it forever. Financial planners believe it is important to review mutual fund i...
- Retail investors may skip Aditya Birla SL Mutual Fund's pharma NFOIn addition to drug makers, the scheme will also invest in allied segments
Load More
